Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting

被引:117
作者
Scazzocchio, Elena [1 ,2 ,3 ]
Figueras, Francesc [1 ,2 ]
Crispi, Fatima [1 ,2 ]
Meler, Eva [1 ,2 ,3 ]
Masoller, Narcs [1 ,2 ]
Mula, Raquel [1 ,2 ]
Gratacos, Eduard [1 ,2 ]
机构
[1] Univ Barcelona, Dept Maternal Fetal Med, Inst Clin Gynecol Obstet & Neonatol, Hosp Clin,Inst Invest Biomed August Pi & Sunyer, E-08028 Barcelona, Spain
[2] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain
[3] Inst Univ Dexeus, Dept Obstet Gynecol & Reprod Med, Barcelona, Spain
关键词
blood pressure; preeclampsia; screening; uterine artery Doppler; UTERINE ARTERY DOPPLER; HYPERTENSIVE DISORDERS; PAPP-A; BIOCHEMICAL MARKERS; GROWTH RESTRICTION; BLOOD-PRESSURE; PREGNANCY; PREDICTION; GESTATION; CLASSIFICATION;
D O I
10.1016/j.ajog.2012.12.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We sought to evaluate the effectiveness of an integrated first-trimester screening test to predict preeclampsia (PE). STUDY DESIGN: A prospective cohort of singleton pregnancies underwent routine first-trimester screening from 2009 through 2011 (n = 5759). A logistic regression-based predictive model for early-and late-onset PE was constructed based on: maternal characteristics; levels of pregnancy-associated plasma protein-A and free beta-human chorionic gonadotropin at 8-12 weeks; and blood pressure and uterine artery Doppler at 11.0-13.6 weeks. RESULTS: Of the 5170 enrolled participants, 136 (2.6%) developed PE (early PE: 26 [0.5%]; late PE: 110 [2.1%]). At 5% and 10% false-positive rates, detection rates were 69.2% and 80.8% for early PE (area under the curve, 0.95; 95% confidence interval, 0.94-0.98) and 29.4% and 39.6% for late PE (area under the curve, 0.71; 95% confidence interval, 0.66-0.76), respectively. CONCLUSION: First-trimester screening combining maternal factors with uterine artery Doppler, blood pressure, and pregnancy-associated plasma protein-A is useful to predict PE in a routine care setting.
引用
收藏
页码:203.e1 / 203.e10
页数:10
相关论文
共 29 条
  • [1] Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy
    Akolekar, Ranjit
    Minekawa, Ryoko
    Veduta, Alina
    Romero, Ximena C.
    Nicolaides, Kypros H.
    [J]. PRENATAL DIAGNOSIS, 2009, 29 (08) : 753 - 760
  • [2] The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
    Brown, MA
    Lindheimer, MD
    de Swiet, M
    Van Assche, A
    Moutquin, JM
    [J]. HYPERTENSION IN PREGNANCY, 2001, 20 (01) : IX - XIV
  • [3] Acetylsalicylic Acid for the Prevention of Preeclampsia and Intra-uterine Growth Restriction in Women with Abnormal Uterine Artery Doppler: A Systematic Review and Meta-analysis
    Bujold, Emmanuel
    Morency, Anne-Maude
    Roberge, Stephanie
    Lacasse, Yves
    Forest, Jean-Claude
    Giguere, Yves
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2009, 31 (09) : 818 - 826
  • [4] Casals E, 1999, PRENATAL DIAG, V19, P8, DOI 10.1002/(SICI)1097-0223(199901)19:1<8::AID-PD460>3.0.CO
  • [5] 2-1
  • [6] Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction
    Crispi, Fatima
    Dominguez, Carmen
    Llurba, Elisa
    Martin-Gallan, Pitar
    Cabero, Luis
    Gratacos, Eduard
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) : 201 - 207
  • [7] Screening for Pre-eclampsia-Lessons from Aneuploidy Screening
    Cuckle, H. S.
    [J]. PLACENTA, 2011, 32 : S42 - S48
  • [8] The Global Impact of Pre-eclampsia and Eclampsia
    Duley, Lelia
    [J]. SEMINARS IN PERINATOLOGY, 2009, 33 (03) : 130 - 137
  • [9] Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia
    Foidart, J. -M.
    Munaut, C.
    Chantraine, F.
    Akolekar, R.
    Nicolaides, K. H.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2010, 35 (06) : 680 - 687
  • [10] Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study
    Gardosi, J
    Kady, SM
    McGeown, P
    Francis, A
    Tonks, A
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7525): : 1113 - 1117